Estrogen receptor interaction with co-activators and co-repressors☆

Steroids - Tập 65 Số 5 - Trang 227-251 - 2000
Carolyn M. Klinge1
1Department of Biochemistry and Molecular Biology, University of Louisville School of Medicine, Louisville, KY 40292, USA. [email protected]

Tóm tắt

Từ khóa


Tài liệu tham khảo

Couse, 1999, Estrogen receptor null mice, Endocr Rev, 20, 358, 10.1210/er.20.3.358

Klinge, 1997, Hsp70 is not required for high affinity binding of purified calf uterine estrogen receptor to estrogen response element DNA in vitro, J Steroid Biochem Mol Biol, 63, 283, 10.1016/S0960-0760(97)00091-5

Ogawa, 1998, The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro, Biochem Biophys Res Commun, 243, 122, 10.1006/bbrc.1997.7893

Laudet, 1997, Evolution of the nuclear receptor superfamily, J Mol Endocrinol, 19, 207, 10.1677/jme.0.0190207

Kuiper, 1998, The estrogen receptor beta subtype, Front Neuroendocrinol, 19, 253, 10.1006/frne.1998.0170

Montano, 1995, The carboxy-terminal F domain of the human estrogen receptor, Mol Endocrinol, 9, 814, 10.1210/me.9.7.814

McInerney, 1996, Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation, J Biol Chem, 271, 24172, 10.1074/jbc.271.39.24172

Metzger, 1995, Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells, J Biol Chem, 270, 9535, 10.1074/jbc.270.16.9535

Danielian, 1992, Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors, EMBO J, 11, 1025, 10.1002/j.1460-2075.1992.tb05141.x

Joel, 1998, Estradiol-induced phosphorylation of Serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase, J Biol Chem, 273, 13317, 10.1074/jbc.273.21.13317

Ali, 1993, Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region, EMBO J, 12, 1153, 10.1002/j.1460-2075.1993.tb05756.x

Rogatsky, 1999, Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex, J Biol Chem, 274, 22296, 10.1074/jbc.274.32.22296

Berry, 1990, Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen, EMBO J, 9, 2811, 10.1002/j.1460-2075.1990.tb07469.x

Green, 1987, Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor, Nature, 325, 75, 10.1038/325075a0

Kumar, 1988, The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer, Cell, 55, 145, 10.1016/0092-8674(88)90017-7

Picard, 1990, Signal transduction by steroid hormones, Cell Regul, 1, 291, 10.1091/mbc.1.3.291

Ylikomi, 1992, Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors, EMBO J, 11, 3681, 10.1002/j.1460-2075.1992.tb05453.x

Safer, 1998, Defective release of co-repressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone, J Biol Chem, 273, 30175, 10.1074/jbc.273.46.30175

Jackson TA, Richer JK, Bain DL, Takimoto GS, Tung l, Horwitz KB. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding co-activator L7/SPA and the co-repressors N-CoR or SMRT. Mol Endocrinol 1997;11:693–705.

Bourguet, 1995, Crystal structure of the ligand-binding domain of the human nuclear receptor RXRα, Nature, 375, 377, 10.1038/375377a0

Renaud, 1995, Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid, Nature, 378, 681, 10.1038/378681a0

Wagner, 1995, A structural role for hormone in the thyroid hormone receptor. A structural role for hormone in the thyroid hormone receptor, Nature, 378, 690, 10.1038/378690a0

Brzozowski, 1997, Molecular basis of agonism and antagonism in the oestrogen receptor, Nature, 389, 753, 10.1038/39645

Shiau, 1998, The structural basis of estrogen receptor/co-activator recognition and the antagonism of this interaction by tamoxifen, Cell, 95, 927, 10.1016/S0092-8674(00)81717-1

Durand, 1994, Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor, EMBO J, 13, 5370, 10.1002/j.1460-2075.1994.tb06872.x

Beato, 1996, Interaction of steroid hormone receptors with transcription factors involves chromatin remodeling, J Steroid Biochem Mol Biol, 56, 47, 10.1016/0960-0760(95)00223-5

Horwitz, 1996, Nuclear receptor co-activators and co-repressors, Mol Endocrinol, 10, 1167, 10.1210/me.10.10.1167

McKenna, 1999, Nuclear receptor co-regulators, Endocr Rev, 20, 321, 10.1210/er.20.3.321

Seielstad, 1995, Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis, Biochemistry, 34, 12605, 10.1021/bi00039a016

Klein–Hitpass, 1988, A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor, Nucleic Acids Res, 16, 647, 10.1093/nar/16.2.647

Klock, 1987, Oestrogen and glucocorticoid responsive elements are closely related but distinct, Nature, 329, 734, 10.1038/329734a0

Klinge, 1992, Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro, Cancer Res, 52, 1073

Klinge, 1992, Antiestrogen-liganded estrogen receptor interaction with estrogen responsive element DNA in vitro, J Steroid Biochem Mol Biol, 43, 249, 10.1016/0960-0760(92)90159-G

Klinge, 1996, Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor when the receptor binds estrogen response element DNA, J Steroid Biochem Mol Biol, 57, 51, 10.1016/0960-0760(95)00246-4

Klinge, 1996, Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro, Steroids, 61, 278, 10.1016/0039-128X(95)00219-G

Klinge, 1997, Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro, Nucleic Acids Res, 25, 1903, 10.1093/nar/25.10.1903

Anolik, 1993, Differential impact of flanking sequences on estradiol- versus 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA, J Steroid Biochem Mol Biol, 46, 713, 10.1016/0960-0760(93)90312-K

Anolik, 1995, Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand, Biochemistry, 34, 2511, 10.1021/bi00008a015

Anolik, 1996, Stability of the ligand of estrogen response element-bound estrogen receptor depends on flanking sequences and cellular factors, J Steroid Biochem Mol Biol, 59, 413, 10.1016/S0960-0760(96)00129-X

Driscoll, 1998, Sequence requirements for estrogen receptor binding to estrogen response elements, J Biol Chem, 273, 29321, 10.1074/jbc.273.45.29321

Walker, 1984, Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDL II genes, Nucleic Acids Res, 12, 8611, 10.1093/nar/12.22.8611

Wahli, 1989, Cis- and trans- acting elements of the estrogen-regulated vitellogenin gene B1 of Xenopus laevis, J Steroid Biochem, 34, 17, 10.1016/0022-4731(89)90062-9

Hache, 1983, The 5′ noncoding and flanking regions of the avian very low density apolipoprotein II and serum albumin genes. Homologies with the egg white protein genes, J Biol Chem, 258, 4556, 10.1016/S0021-9258(18)32659-0

Jeltsch, 1987, Structure of the human oestrogen-responsive gene pS2, Nucleic Acids Res, 15, 1401, 10.1093/nar/15.4.1401

Richard, 1990, The human oxytocin gene promoter is regulated by estrogens, J Biol Chem, 265, 6098, 10.1016/S0021-9258(19)39297-X

Weisz, 1990, Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor, Nucleic Acids Res, 18, 5097, 10.1093/nar/18.17.5097

Weisz, 1988, Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus, Mol Endocrinol, 2, 816, 10.1210/mend-2-9-816

El–Ashry, 1996, Estrogen induction of TGF-α is mediated by an estrogen response element composed of two imperfect palindromes, J Steroid Biochem Mol Biol, 59, 261, 10.1016/S0960-0760(96)00118-5

Teng, 1992, Differential molecular mechanism of the estrogen action that regulates lactoferrin gene in human and mouse, Mol Endocrinol, 6, 1969, 10.1210/me.6.11.1969

Berwaer, 1994, Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene, Mol Endocrinol, 8, 635, 10.1210/me.8.5.635

Kraus, 1994, Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene, Mol Endocrinol, 8, 952, 10.1210/me.8.8.952

Augereau, 1994, Characterization of the proximal estrogen-responsive element of human cathepsin D gene, Mol Endocrinol, 8, 693, 10.1210/me.8.6.693

Norris, 1996, Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity, Mol Endocrinol, 10, 1605, 10.1210/me.10.12.1605

Krishnan, 1994, Estrogen receptor-SP1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells, J Biol Chem, 269, 15912, 10.1016/S0021-9258(17)40767-8

Porter, 1996, Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression, Mol Endocrinol, 10, 1371, 10.1210/me.10.11.1371

Porter, 1997, Functional synergy between the transcription factor Sp1 and the estrogen receptor, Mol Endocrinol, 11, 1569, 10.1210/me.11.11.1569

Wang, 1998, Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes, Nucleic Acids Res, 26, 3044, 10.1093/nar/26.12.3044

Qin, 1999, Transcriptional activation of insulin-like growth factor-binding protein-4 by 17β-estradiol in MCF-7 cells, Endocrinology, 140, 2501, 10.1210/en.140.6.2501

Webb, 1995, Tamoxifen activation of the estrogen receptor/AP-1 pathway, Mol Endocrinol, 9, 443, 10.1210/me.9.4.443

Paech K, Webb P, Kuiper GG, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997;277:1508–10.

Sabbah, 1992, Estrogen receptor-induced bending of the Xenopus vitellogenin A2 gene hormone response element, Biochem Biophys Res Comm, 185, 944, 10.1016/0006-291X(92)91718-6

Nardulli, 1992, Binding of the estrogen receptor DNA-binding domain to the estrogen response element induces DNA bending, Mol Cell Biol, 12, 2037, 10.1128/MCB.12.5.2037

Nardulli AM, Greene. GL, Shapiro DJ. Human estrogen receptor bound to an estrogen response element bends DNA. Mol Endocrinol 1993;7:331–40.

Nardulli, 1995, Estrogen receptor-induced DNA bending, Mol Endocrinol, 9, 1064, 10.1210/me.9.8.1064

Potthoff, 1996, Effects of wild type and mutant estrogen receptors on DNA flexibility, DNA bending, and transcription activation, Mol Endocrinol, 10, 1095, 10.1210/me.10.9.1095

Kim, 1997, Prebending the estrogen response element destabilized binding of the estrogen receptor DNA binding domain, Mol Cell Biol, 17, 3173, 10.1128/MCB.17.6.3173

Kerppola, 1991, Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations, Cell, 66, 317, 10.1016/0092-8674(91)90621-5

Kerppola, 1991, DNA bending by Fos and Jun, Science, 254, 1210, 10.1126/science.1957173

Kerppola, 1997, The transcription activation domains of Fos and Jun induce DNA bending through electrostatic interactions, EMBO J, 16, 2907, 10.1093/emboj/16.10.2907

Onate, 1994, The DNA-bending protein HMG-I enhances progesterone receptor binding to its target DNA sequences, Mol Cell Biol, 14, 3376, 10.1128/MCB.14.5.3376

Prendergast, 1996, Progesterone receptor-induced bending of its target DNA, Mol Endocrinol, 10, 393, 10.1210/me.10.4.393

Boonyaratanakornkit, 1998, High-Mobility Group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells, Mol Cell Biol, 18, 4471, 10.1128/MCB.18.8.4471

Zhang, 1999, HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells, Mol Endocrinol, 13, 632, 10.1210/me.13.4.632

Denton, 1992, Estrogen receptor phosphorylation. Hormonal dependence and consequence on specific DNA binding, J Biol Chem, 267, 7263, 10.1016/S0021-9258(18)42514-8

Weigel, 1998, Ligand-independent activation of steroid hormone receptors, J Mol Med, 76, 469, 10.1007/s001090050241

Greenblatt, 1997, RNA polymerase II holoenzyme and transcriptional regulation, Curr Opin Cell Biol, 9, 310, 10.1016/S0955-0674(97)80002-6

Roeder, 1996, The role of general initiation factors in transcription by RNA polymerase II, Trends Biochem Sci, 21, 327, 10.1016/S0968-0004(96)10050-5

Verrijzer, 1996, TAFs mediate transcriptional activation and promoter selectivity, Trends Biochem Sci, 21, 338, 10.1016/0968-0004(96)10044-X

Klein–Hitpass, 1998, Targets of activated steroid hormone receptors, J Mol Med, 76, 490, 10.1007/s001090050243

Ing, 1992, Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II), J Biol Chem, 267, 17617, 10.1016/S0021-9258(19)37087-5

Sadovsky, 1995, Transcriptional activators differ in their responses to over-expression of TATA-box-binding protein, Mol Cell Biol, 15, 1554, 10.1128/MCB.15.3.1554

Jacq, 1994, Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor, Cell, 79, 107, 10.1016/0092-8674(94)90404-9

May, 1996, Human TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptors, EMBO J, 15, 3093, 10.1002/j.1460-2075.1996.tb00672.x

Mengus, 1997, Human TAF(II)135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells, Genes Dev, 11, 1381, 10.1101/gad.11.11.1381

Wu, 1999, Isolation of mouse TFIID and functional characterization of TBP and TFIID in mediating estrogen receptor and chromatin transcription, J Biol Chem, 274, 23480, 10.1074/jbc.274.33.23480

Meyer, 1989, Steroid hormone receptors compete for factors that mediate their enhancer function, Cell, 57, 433, 10.1016/0092-8674(89)90918-5

Ding, 1998, Nuclear receptor-binding sites of co-activators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor co-activator 1 (SRC-1), Mol Endocrinol, 12, 302, 10.1210/me.12.2.302

Feng, 1998, Hormone-dependent co-activator binding to a hydrophobic cleft on nuclear receptors, Science, 280, 1747, 10.1126/science.280.5370.1747

Darimont, 1998, Structure and specificity of nuclear receptor-co-activator interactions, Genes Dev, 12, 3343, 10.1101/gad.12.21.3343

Hong, 1999, An additional region of co-activator GRIP1 required for interaction with the hormone-binding domains of a subset of nuclear receptors, J Biol Chem, 274, 3496, 10.1074/jbc.274.6.3496

Misiti, 1998, Expression and hormonal regulation of co-activator and co-repressor genes, Endocrinology, 139, 2493, 10.1210/en.139.5.2493

Folkers, 1998, Promoter architecture, cofactors, and orphan receptors contribute to cell-specific activation of the retinoic acid receptor beta2 promoter, J Biol Chem, 273, 32200, 10.1074/jbc.273.48.32200

Halachmi, 1994, Estrogen receptor-associated proteins, Science, 264, 1455, 10.1126/science.8197458

Onate, 1995, Sequence and characterization of a co-activator for the steroid hormone receptor superfamily, Science, 270, 1354, 10.1126/science.270.5240.1354

McInerney, 1996, Analysis of estrogen receptor transcriptional enhancement by a nuclear receptor co-activator, Proc Natl Acad Sci USA, 93, 10069, 10.1073/pnas.93.19.10069

Smith, 1997, Co-activator and co-repressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen, Mol Endocrinol, 11, 657, 10.1210/me.11.6.657

Webb, 1998, Estrogen receptor activation function 1 works by binding p160 co-activator proteins, Mol Endocrinol, 12, 1605, 10.1210/me.12.10.1605

Heery, 1997, A signature motif in transcriptional co-activators mediates binding to nuclear receptors, Nature, 387, 733, 10.1038/42750

Henttu, 1997, AF-2 activity and recruitment of steroid receptor co-activator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors, Mol Cell Biol, 17, 1832, 10.1128/MCB.17.4.1832

Mak HY, Hoare S, A. PM, Henttu, Parker MG. Molular determinants of the estrogen receptor-co-activator interface. Mol Cell Biol 1999;19:3895–903.

Tremblay, 1997, Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β, Mol Endocrinol, 11, 353, 10.1210/me.11.3.353

Cowley, 1999, A comparison of transcriptional activation by ER alpha and ER beta, J Steroid Biochem Mol Biol, 69, 165, 10.1016/S0960-0760(99)00055-2

Cowley, 1997, Estrogen receptors alpha and beta form heterodimers on DNA, J Biol Chem, 272, 19858, 10.1074/jbc.272.32.19858

Tremblay, 1999, Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor α-beta heterodimeric complex, Mol Cell Biol, 19, 1919, 10.1128/MCB.19.3.1919

Shim, 1999, Segregation of steroid receptor co-activator-1 from steroid receptors in mammary epithelium, Proc Natl Acad Sci U S A, 96, 208, 10.1073/pnas.96.1.208

Xu, 1998, Partial hormone resistance in mice with disruption of the steroid receptor co-activator-1 (SRC-1) gene, Science, 279, 1922, 10.1126/science.279.5358.1922

Spencer, 1997, Steroid receptor co-activator-1 is a histone acetyltransferase, Nature, 389, 194, 10.1038/38304

Struhl, 1998, Histone acetylation and transcriptional regulatory mechanisms, Genes Dev, 12, 599, 10.1101/gad.12.5.599

Sternglanz, 1996, Histone acetylation, Trends In Biochem Sci, 21, 357, 10.1016/S0968-0004(96)30034-0

Pennisi, 1997, Opening the way to gene activity, Science, 275, 155, 10.1126/science.275.5297.155

Korzus, 1998, Transcription factor-specific requirements for co-activators and their acetyltransferase functions, Science, 279, 703, 10.1126/science.279.5351.703

Tsukiyama, 1997, Chromatin remodeling and transcription, Curr Opin Gen Dev, 7, 182, 10.1016/S0959-437X(97)80127-X

Wang, 1997, Histone acetyltransferase activity is conserved between yeast and human GCN5 and is required for complementation of growth and transcriptional activation, Mol Cell Biol, 17, 519, 10.1128/MCB.17.1.519

Imhof, 1997, Acetylation of general transcription factors by histone acetyltransferases, Curr Biol, 7, 689, 10.1016/S0960-9822(06)00296-X

Shibata, 1997, Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action, Recent Prog Horm Res, 52, 141

Struhl, 1996, Chromatin structure and RNA polymerase II connection, Cell, 84, 179, 10.1016/S0092-8674(00)80970-8

Zhou, 1998, Nuclear receptors have distinct affinities for co-activators, Mol Endocrinol, 12, 1594, 10.1210/me.12.10.1594

Eng, 1998, Different classes of co-activators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain, J Biol Chem, 273, 28371, 10.1074/jbc.273.43.28371

Lee, 1998, Steroid receptor co-activator-1 co-activates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits, J Biol Chem, 273, 16651, 10.1074/jbc.273.27.16651

Ikeda, 1999, CBP-dependent and independent enhancing activity of steroid receptor co-activator-1 in thyroid hormone receptor-mediated transactivation, Mol Cell Endocrinol, 147, 103, 10.1016/S0303-7207(98)00211-1

Takeshita, 1996, Molular cloning and properties of a full-length putative thyroid hormone receptor co-activator, Endocrinology, 137, 3594, 10.1210/en.137.8.3594

Zwijsen, 1998, Ligand-independent recruitment of steroid receptor co-activators to estrogen receptor by cyclin D, Genes Dev, 12, 3488, 10.1101/gad.12.22.3488

Zwijsen, 1997, CDK-independent activation of estrogen receptor by cyclin D1, Cell, 88, 405, 10.1016/S0092-8674(00)81879-6

Na, 1998, Steroid receptor co-activator-1 interacts with the p50 subunit and co-activates nuclear factor kappaB-mediated transactivations, J Biol Chem, 273, 10831, 10.1074/jbc.273.18.10831

Gottlicher, 1998, Transcriptional cross-talk, the second mode of steroid hormone receptor action, J Mol Med, 76, 480, 10.1007/s001090050242

Kurebayashi, 1997, Characterization of mechanisms of interleukin-6 (IL-6) gene repression by estrogen receptor, J Steroid Biochem Mol Biol, 60, 11, 10.1016/S0960-0760(96)00175-6

McKay, 1998, Cross-talk between Nuclear Factor-kB and the steroid hormone receptors, Mol Endocrinol, 12, 45, 10.1210/me.12.1.45

Berns, 1998, Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer, Breast Cancer Res Treat, 48, 87, 10.1023/A:1005903226483

Li, 1998, The receptor-associated co-activator 3 activates transcription through CREB-binding protein recruitment and autoregulation, J Biol Chem, 273, 5948, 10.1074/jbc.273.10.5948

Hong, 1997, GRIP1, a transcriptional co-activator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors, Mol Cell Biol, 17, 2735, 10.1128/MCB.17.5.2735

Voegel, 1996, TIF2, a 160kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors, EMBO J, 15, 3667, 10.1002/j.1460-2075.1996.tb00736.x

Webb, 1999, The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions, Mol Endocrinol, 13, 1672, 10.1210/me.13.10.1672

Johansson, 1999, -Å, Treuter E, The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta. J Biol Chem, 274, 345

Lopez, 1999, Titration by estrogen receptor activation function-2 of targets that are downstream from co-activators, Mol Endocrinol, 13, 897, 10.1210/me.13.6.897

Anzick, 1997, AIB1, a steroid receptor co-activator amplified in breast and ovarian cancer, Science, 277, 965, 10.1126/science.277.5328.965

Chen, 1997, Nuclear receptor co-activator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300, Cell, 90, 569, 10.1016/S0092-8674(00)80516-4

Li, 1997, RAC3, a steroid/nuclear receptor-associated co-activator that is related to SRC-1 and TIF2, Proc Natl Acad Sci USA, 94, 8479, 10.1073/pnas.94.16.8479

Takeshita, 1997, TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor co-activator-1, J Biol Chem, 272, 27629, 10.1074/jbc.272.44.27629

Torchia, 1997, The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function, Nature, 387, 677, 10.1038/42652

Kim, 1998, Molular cloning of xSRC-3, a novel transcription co-activator from Xenopus, that is related to AIB1, p/CIP, and TIF2, Mol Endocrinol, 12, 1038, 10.1210/me.12.7.1038

Suen, 1998, A transcriptional co-activator, steroid receptor co-activator-3, selectively augments steroid receptor transcriptional activity, J Biol Chem, 273, 27645, 10.1074/jbc.273.42.27645

Chen, 1999, Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase, Cell, 98, 675, 10.1016/S0092-8674(00)80054-9

Bautista, 1998, In breast cancer, amplification of the steroid receptor co-activator gene AIB1 is correlated with estrogen and progesterone receptor positivity, Clin Cancer Res, 4, 2925

Ghadimi, 1999, Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor co-activator gene in pancreatic carcinomas, Am J Pathol, 154, 525, 10.1016/S0002-9440(10)65298-4

Cavailles, 1994, Interaction of proteins with transcriptionally active estrogen receptors, Proc Natl Acad Sci USA, 91, 10009, 10.1073/pnas.91.21.10009

Cavailles, 1995, Nuclear factor RIP 140 modulates transcriptional activation by the estrogen receptor, EMBO J, 14, 3741, 10.1002/j.1460-2075.1995.tb00044.x

Peters, 1999, Estrogen receptor domains E and F, Mol Endocrinol, 13, 286, 10.1210/me.13.2.286

L’Horset, 1996, RIP-140 interacts with multiple nuclear receptors by means of two distinct sites, Mol Cell Biol, 16, 6029, 10.1128/MCB.16.11.6029

Swanson, 1993, The AH-receptor, Pharmacogenetics, 3, 213, 10.1097/00008571-199310000-00001

Kumar, 1999, Differential recruitment of co-activator RIP140 by Ah and estrogen receptors, Absence of a role for lxxll motifs. J Biol Chem, 274, 22155

Klinge, 1999, The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements, Mol Cell Endocrinol, 157, 105, 10.1016/S0303-7207(99)00165-3

White, 1997, Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine, EMBO J, 16, 1427, 10.1093/emboj/16.6.1427

Arnold, 1995, Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro, Mol Endocrinol, 9, 24, 10.1210/me.9.1.24

Zhang, 1997, An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer, Cancer Res, 57, 1244

Chuang, 1997, Activities in Pit-1 determine whether receptor interacting protein 140 activates or inhibits Pit-1/nuclear receptor transcriptional synergy, Mol Endocrinol, 11, 1332, 10.1210/me.11.9.1332

Schaufele, 1999, Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins, Mol Endocrinol, 13, 935, 10.1210/me.13.6.935

Harnish, 1998, Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing, J Biol Chem, 273, 9270, 10.1074/jbc.273.15.9270

Le Douarin, 1995, The N terminal part of TIF-1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18, EMBO J, 14, 2020, 10.1002/j.1460-2075.1995.tb07194.x

Thénot, 1997, Differential interaction of nuclear receptors with the putative human transcriptional co-activator hTIF1, J Biol Chem, 272, 12062, 10.1074/jbc.272.18.12062

Le Douarin, 1998, TIF1a, J Steroid Biochem Mol Biol, 65, 43, 10.1016/S0960-0760(97)00175-1

Venturini, 1999, TIF1gamma, a novel member of the transcriptional intermediary factor 1 family, Oncogene, 18, 1209, 10.1038/sj.onc.1202655

Fraser, 1998, The putative cofactor TIF1alpha is a protein kinase that is hyperphosphorylated upon interaction with liganded nuclear receptors, J Biol Chem, 273, 16199, 10.1074/jbc.273.26.16199

Yeh, 1997, Cloning and characterization of a specific co-activator, ARA70, for the androgen receptor in human prostate cells, Proc Natl Acad Sci U S A, 93, 5517, 10.1073/pnas.93.11.5517

Yeh, 1998, From estrogen to androgen receptor, Proc Natl Acad Sci U S A, 95, 5527, 10.1073/pnas.95.10.5527

Gao, 1999, RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a co-activator in cotransfection assays, Mol Endocrinol, 13, 1645, 10.1210/me.13.10.1645

Baudino TA, Kraichely DM, Jefcoar SC Jr, Winchester SK, Partridge NC, MacDonald PN. Isolation and characterization of a novel co-activator protein, NCoA-62, involved in vitamin D-mediated transcription. J Biol Chem 1998;273:16434–41.

Brady, 1999, Tip60 is a nuclear hormone receptor co-activator, J Biol Chem, 274, 17599, 10.1074/jbc.274.25.17599

Zhu, 1997, Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor, J Biol Chem, 272, 25500, 10.1074/jbc.272.41.25500

Yuan, 1998, The TRAP220 component of a thyroid hormone receptor- associated protein (TRAP) co-activator complex interacts directly with nuclear receptors in a ligand-dependent fashion, Proc Natl Acad Sci U S A, 95, 7939, 10.1073/pnas.95.14.7939

Zhu, 1999, Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer, Proc Natl Acad Sci USA, 96, 10848, 10.1073/pnas.96.19.10848

Mink, 1997, Interaction and functional collaboration of p300 and C/EBPbeta, Mol Cell Biol, 17, 6609, 10.1128/MCB.17.11.6609

Gu, 1997, Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain, Cell, 90, 595, 10.1016/S0092-8674(00)80521-8

Gu, 1997, Synergistic activation of transcription by CBP and p53, Nature, 387, 819, 10.1038/42972

Perkins, 1997, Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 co-activator, Science, 275, 523, 10.1126/science.275.5299.523

Yang, 1996, A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A, Nature, 382, 319, 10.1038/382319a0

Jenster, 1997, Steroid receptor induction of gene transcription, Proc Natl Acad Sci USA, 94, 7879, 10.1073/pnas.94.15.7879

Voegel, 1998, The co-activator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways, EMBO J, 17, 507, 10.1093/emboj/17.2.507

Smith, 1996, CREB binding protein acts synergistically with steroid receptor co-activator-1 to enhance steroid receptor-dependent transcription, Proc Natl Acad Sci USA, 93, 8884, 10.1073/pnas.93.17.8884

Yao, 1996, The nuclear hormone receptor co-activator SRC-1 is a specific target of p300, Proc Natl Acad Sci USA, 93, 10026, 10.1073/pnas.93.20.10626

Kwok, 1994, Nuclear protein CBP is a co-activator for the transcription factor CREB, Nature, 370, 223, 10.1038/370223a0

Kee, 1996, Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator, J Biol Chem, 271, 2373, 10.1074/jbc.271.5.2373

McKenna, 1998, Distinct steady-state nuclear receptor co-regulator complexes exist in vivo, Proc Natl Acad Sci USA, 95, 11697, 10.1073/pnas.95.20.11697

Ogryzko, 1996, The transcriptional co-activators p300 and CBP are histone acetyltransferases, Cell, 87, 953, 10.1016/S0092-8674(00)82001-2

Bannister, 1996, The CBP co-activator is a histone acetyltransferase, Nature, 384, 641, 10.1038/384641a0

Boyes, 1998, Regulation of activity of the transcription factor GATA-1 by acetylation, Nature, 396, 594, 10.1038/25166

Munshi, 1998, Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome, Mol Cell, 2, 457, 10.1016/S1097-2765(00)80145-8

Schiltz, 1999, Overlapping but distinct patterns of histone acetylation by the human co-activators p300 and PCAF within nucleosomal substrates, J Biol Chem, 274, 1189, 10.1074/jbc.274.3.1189

Kamei, 1996, A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors, Cell, 85, 403, 10.1016/S0092-8674(00)81118-6

Kraus, 1998, p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation, Genes Dev, 12, 331, 10.1101/gad.12.3.331

Nagpal, 1999, Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor, J Biol Chem, 274, 22563, 10.1074/jbc.274.32.22563

Van Lint, 1996, The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation, Gene Exp, 5, 245

Espinos, 1999, Cooperation between phosphorylation and acetylation processes in transcriptional control, Mol Cell Biol, 19, 3474, 10.1128/MCB.19.5.3474

Dallas, 1998, p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes, Mol Cell Biol, 18, 3596, 10.1128/MCB.18.6.3596

Johnston, 1999, Identification of a novel SNF2/SWI2 protein family member, SRCAP, which interacts with CREB-binding protein, J Biol Chem, 274, 16370, 10.1074/jbc.274.23.16370

Yao, 1998, Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300, Cell, 93, 361, 10.1016/S0092-8674(00)81165-4

Endoh, 1999, Purification and identification of p68 RNA helicase acting as a transcriptional co-activator specific for the activation function 1 of human estrogen receptor alpha, Mol Cell Biol, 19, 5363, 10.1128/MCB.19.8.5363

Nawaz, 1999, The Angelman syndrome-associated protein, E6-AP, is a co-activator for the nuclear hormone receptor Superfamily, Mol Cell Biol, 19, 1182, 10.1128/MCB.19.2.1182

Patton, 1998, Combinatorial control in ubiquitin-dependent proteolysis, Trends Genet, 14, 236, 10.1016/S0168-9525(98)01473-5

Nawaz, 1999, Proteasome-dependent degradation of the human estrogen receptor, Proc Natl Acad Sci USA, 96, 1858, 10.1073/pnas.96.5.1858

Kallio, 1999, Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway, J Biol Chem, 274, 6519, 10.1074/jbc.274.10.6519

Hatakeyama, 1999, Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1, Proc Natl Acad Sci USA, 96, 3859, 10.1073/pnas.96.7.3859

Salvat, 1999, Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?, Mol Biol Rep, 26, 45, 10.1023/A:1006960021281

Lanz, 1999, A steroid receptor co-activator, SRA, functions as an RNA and is present in an SRC-1 complex, Cell, 97, 17, 10.1016/S0092-8674(00)80711-4

Zeiner, 1995, A protein that interacts with members of the nuclear hormone receptor family, Proc Natl Acad Sci USA, 92, 11465, 10.1073/pnas.92.25.11465

Kullmann, 1998, RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis, J Biol Chem, 273, 14620, 10.1074/jbc.273.23.14620

Zeiner, 1997, Mammalian protein RAP46, EMBO J, 16, 5483, 10.1093/emboj/16.18.5483

Packham, 1997, Mammalian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation, Biochem J, 328, 807, 10.1042/bj3280807

Froesch, 1998, BAG-1L protein enhances androgen receptor function, J Biol Chem, 273, 11660, 10.1074/jbc.273.19.11660

Yang, 1998, Human BAG-1/RAP46 protein is generated as four isoforms by alternative translation initiation and overexpressed in cancer cells, Oncogene, 17, 981, 10.1038/sj.onc.1202032

Liu, 1998, Interaction of BAG-1 with retinoic acid receptor and Its Inhibition of retinoic acid-induced apoptosis in cancer cells, J Biol Chem, 273, 16985, 10.1074/jbc.273.27.16985

Castoria, 1988, In vitro interaction of estradiol receptor with Ca2+-calmodulin, Mol Endocrinol, 2, 167, 10.1210/mend-2-2-167

Bouhoute, 1995, Modulation of estradiol and DNA binding to estrogen receptor upon association with calmodulin, Biochem Biophys Res Commun, 208, 748, 10.1006/bbrc.1995.1401

Biswas, 1998, Calmodulin is essential for estrogen receptor interaction with its motif and activation of responsive promoter, J Biol Chem, 273, 33817, 10.1074/jbc.273.50.33817

Lee, 1995, Interaction of thyroid hormone receptor with a conserved transcriptional mediator, Nature, 374, 91, 10.1038/374091a0

Surabhi, 1998, Physical linkage of the human growth hormone gene family and the thyroid hormone receptor interacting protein-1 gene on chromosome 17, Gene, 212, 67, 10.1016/S0378-1119(98)00149-8

Kim, 1994, A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II, Cell, 77, 599, 10.1016/0092-8674(94)90221-6

vom Baur, 1996, Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1, EMBO J, 15, 110, 10.1002/j.1460-2075.1996.tb00339.x

Fraser, 1997, SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase, J Biol Chem, 272, 7122, 10.1074/jbc.272.11.7122

Huang, 1998, Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both co-repressors and co-activators, EMBO J, 17, 3398, 10.1093/emboj/17.12.3398

Cote, 1994, Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex, Science, 265, 53, 10.1126/science.8016655

Burns, 1997, The yeast SWI-SNF complex facilitates binding of a transcriptional activator to nucleosomal sites in vivo, Mol Cell Biol, 17, 4811, 10.1128/MCB.17.8.4811

Pazin, 1997, SWI2/SNF2 and related proteins, Cell, 88, 737, 10.1016/S0092-8674(00)81918-2

Bazett–Jones, 1999, The SWI/SNF complex creates loop domains in DNA and polynucleosome arrays and can disrupt DNA-histone Contacts within these domains, Mol Cell Biol, 19, 1470, 10.1128/MCB.19.2.1470

Yoshinaga, 1992, Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors, Science, 258, 1598, 10.1126/science.1360703

Ichinose, 1997, Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2, Gene, 188, 95, 10.1016/S0378-1119(96)00785-8

Chiba, 1994, Two human homologues of Saccharomyces cerevisiae SW12/SNF2 and Drosophila brahma are transcriptional co-activators cooperating with the estrogen receptor and the retinoid acid receptor, Nucl Acids Res, 22, 1815, 10.1093/nar/22.10.1815

Bortvin, 1996, Evidence that Spt6p controls chromatin structure by a direct interaction with histones, Science, 272, 1473, 10.1126/science.272.5267.1473

Compagnone–Post, 1996, Mutations in the SPT4, SPT5, and SPT6 genes alter transcription of a subset of histone genes in Saccharomyces cerevisiae, Genetics, 143, 1543, 10.1093/genetics/143.4.1543

Hartzog, 1998, Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae, Genes Dev, 12, 357, 10.1101/gad.12.3.357

Baniahmad, 1995, Enhancement of human estrogen receptor activity by SPT6, Mol Endocrinol, 9, 34, 10.1210/me.9.1.34

vom Baur E, Harbers M, Um SJ, Benecke A, Chambon P, Losson R. The yeast Ada complex mediates the ligand-dependent activation function AF-2 of retinoid X and estrogen receptors. Genes Dev 1998;12:1278–89.

Ikeda, 1999, Activation domain-specific and general transcription stimulation by native histone acetyltransferase complexes, Mol Cell Biol, 19, 855, 10.1128/MCB.19.1.855

Horlein, 1995, Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor, Nature, 377, 397, 10.1038/377397a0

Kurokawa, 1995, Polarity-specific activities of retinoid acid receptors determined by a co-repressor, Nature, 377, 451, 10.1038/377451a0

Chen, 1995, A transcriptional co-repressor that interacts with nuclear hormone receptors, Nature, 377, 454, 10.1038/377454a0

Park, 1999, SMRTe, a silencing mediator for retinoid and thyroid hormone receptors- extended isoform that is more related to the nuclear receptor co-repressor, Proc Natl Acad Sci USA, 96, 3519, 10.1073/pnas.96.7.3519

Alland, 1997, Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression, Nature, 387, 49, 10.1038/387049a0

Heinzel, 1997, A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression, Nature, 387, 43, 10.1038/387043a0

Nagy, 1997, Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase, Cell, 89, 373, 10.1016/S0092-8674(00)80218-4

Gelmetti C, Zhang J, M. F, Minucci S, Pelicci PG, Lazar MA. Aberrant recruitment of the nuclear receptor co-repressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol 1998;18:7185–91.

Lavinsky, 1998, Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes, Proc Natl Acad Sci USA, 95, 2920, 10.1073/pnas.95.6.2920

Zhang, 1998, A nuclear receptor co-repressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor, Mol Endocrinol, 12, 513, 10.1210/me.12.4.513

Schodin, 1995, Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness, J Biol Chem, 270, 31163, 10.1074/jbc.270.52.31163

Montano, 1999, An estrogen receptor-selective co-regulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens, Proc Natl Acad Sci USA, 96, 6947, 10.1073/pnas.96.12.6947

Seol, 1996, An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors, Science, 272, 1336, 10.1126/science.272.5266.1336

Seol, 1997, Novel receptor interaction and repression domains in the orphan receptor SHP, Mol Cell Biol, 17, 7126, 10.1128/MCB.17.12.7126

Seol, 1998, Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner), Mol Endocrinol, 12, 1551, 10.1210/me.12.10.1551

Fan, 1999, BRCA1 inhibition of estrogen receptor signaling in transfected cells, Science, 284, 1354, 10.1126/science.284.5418.1354

Marx, 1997, Possible function found for breast cancer genes, Science, 276, 531, 10.1126/science.276.5312.531

Scully, 1997, BRCA1 is a component of the RNA polymerase II holoenzyme, Proc Natl Acad Sci USA, 94, 5605, 10.1073/pnas.94.11.5605

Dressel, 1999, Alien, a highly conserved protein with characteristics of a co-repressor for members of the nuclear hormone receptor superfamily, Mol Cell Biol, 19, 3383, 10.1128/MCB.19.5.3383

Beato, 1996, Interaction of steroid hormone receptors with the transcription initiation complex, Endocrine Rev, 17, 587, 10.1210/edrv-17-6-587

Uht, 1997, Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element, Endocrinology, 138, 2900, 10.1210/en.138.7.2900

Lee, 1998, Estrogen receptor, a common interaction partner for a subset of nuclear receptors, Mol Endocrinol, 12, 1184, 10.1210/me.12.8.1184

Johnson, 1997, Estrogen-related receptorα1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements, Mol Endocrinol, 11, 342, 10.1210/me.11.3.342

Klinge, 1997, COUP-TF interacts with estrogen receptor, binds to estrogen response elements and half-sites, and modulates estrogen-induced gene expression, J Biol Chem, 272, 31465, 10.1074/jbc.272.50.31465

Klinge, 1999, Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF), J Steroid Biochem Mol Biol, 71, 1, 10.1016/S0960-0760(99)00124-7

Joel, 1998, pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167, Mol Cell Biol, 18, 1978, 10.1128/MCB.18.4.1978

Katzenellenbogen, 1997, Antiestrogens, Breast Cancer Res Treat, 44, 23, 10.1023/A:1005835428423

Walter, 1985, Cloning of the human estrogen receptor cDNA, Proc Natl Acad Sci USA, 82, 7889, 10.1073/pnas.82.23.7889

Kuiper, 1996, Cloning of a novel estrogen receptor expressed in rat prostate and ovary, Proc Natl Acad Sci USA, 93, 5925, 10.1073/pnas.93.12.5925

Mosselman, 1996, ERb, FEBS, 392, 49, 10.1016/0014-5793(96)00782-X

Chang, 1988, Molular cloning of human and rat complementary DNA encoding androgen receptors, Science, 240, 324, 10.1126/science.3353726

Ikeuchi, 1999, cDNA cloning of a novel androgen receptor subtype, J Biol Chem, 274, 25205, 10.1074/jbc.274.36.25205

Misrahi, 1987, Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA, Biochem Biophys Res Commun, 143, 740, 10.1016/0006-291X(87)91416-1

Rousseau–Merck, 1987, Localization of the human progesterone receptor gene to chromosome 11q22-q23, Hum Genet, 77, 280, 10.1007/BF00284486

Weinberger, 1985, Identification of human glucocorticoid receptor complementary DNA clones by epitope selection, Science, 228, 740, 10.1126/science.2581314

Hollenberg, 1985, Primary structure and expression of a functional human glucocorticoid receptor cDNA, Nature, 318, 635, 10.1038/318635a0

Arriza, 1987, Cloning of human mineralocorticoid receptor complementary DNA, Science, 237, 268, 10.1126/science.3037703

Haussler, 1998, The nuclear vitamin D receptor, J Bone Miner Res, 13, 325, 10.1359/jbmr.1998.13.3.325

Lazar, 1993, Thyroid hormone receptors, Endocr Rev, 14, 184

Sap, 1986, The c-erb-A protein is a high-affinity receptor for thyroid hormone, Nature, 324, 635, 10.1038/324635a0

Harding, 1993, The orphan receptor Rev-ErbA alpha activates transcription via a novel response element, Mol Cell Biol, 13, 3113, 10.1128/MCB.13.5.3113

Koenig, 1988, Isolation of a cDNA clone encoding a biologically active thyroid hormone receptor, Proc Natl Acad Sci U S A, 85, 5031, 10.1073/pnas.85.14.5031

Hodin, 1989, Identification of a thyroid hormone receptor that is pituitary-specific, Science, 244, 76, 10.1126/science.2539642

Giguere, 1994, Retinoic acid receptors and cellular retinoid binding proteins, Endocr Rev, 15, 61

Glass, 1994, Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers, Endocrine Rev, 15, 391

Issemann, 1990, Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature, 347, 645, 10.1038/347645a0

Mukherjee, 1994, Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators, J Steroid Biochem Mol Biol, 51, 157, 10.1016/0960-0760(94)90089-2

Schmidt, 1992, Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids, Mol Endocrinol, 6, 1634, 10.1210/me.6.10.1634

Kliewer, 1994, Differential expression and activation of a family of murine peroxisome proliferator-activated receptors, Proc Natl Acad Sci USA, 91, 7355, 10.1073/pnas.91.15.7355

Mangelsdorf, 1995, The RXR heterodimers and orphan receptors, Cell, 83, 841, 10.1016/0092-8674(95)90200-7

Greschik, 1999, , Jean–Marie Wurtz PH, Fabian Köhler, Moras D, Schüle R, Characterization of the DNA-binding and dimerization properties of the nuclear orphan receptor germ cell nuclear factor. Mol Cell Biol, 19, 690

Drewes, 1996, Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes, Mol Cell Biol, 16, 925, 10.1128/MCB.16.3.925

Wong, 1996, Cloning and sequence analysis of the human gene encoding steroidogenic factor 1, J Mol Endocrinol, 17, 139, 10.1677/jme.0.0170139

Hirose, 1995, , DA OB, Jetten AM, RTR: a new member of the nuclear receptor superfamily that is highly expressed in murine testis. Gene, 152, 247

Yan, 1997, Characterization of the response element and DNA binding properties of the nuclear orphan receptor germ cell nuclear factor/retinoid receptor-related testis-associated receptor, J Biol Chem, 272, 10565, 10.1074/jbc.272.16.10565

Greiner, 1996, Functional analysis of retinoid Z receptor β, a brain-specific nuclear orphan receptor, Proc Natl Acad Sci USA, 93, 10105, 10.1073/pnas.93.19.10105

Hirose, 1994, TAK 1, Mol Endocrinol, 8, 1667, 10.1210/me.8.12.1667

Ortiz, 1995, TOR, Mol Endocrinol, 9, 1679, 10.1210/me.9.12.1679

Lee, 1995, Genomic structure, promoter identification, and chromosomal mapping of a mouse nuclear orphan receptor expressed in embryos and adult testes, Genomics, 30, 46, 10.1006/geno.1995.0007

Chinpaisal, 1998, Mechanisms of the mouse orphan nuclear receptor TR2–11-mediated gene suppression, J Biol Chem, 273, 18077, 10.1074/jbc.273.29.18077

Lee, 1997, Identification of direct repeat 4 as a positive regulatory element for the human TR4 orphan receptor, J Biol Chem, 272, 12215, 10.1074/jbc.272.18.12215

Blumberg, 1998, BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites, Genes Dev, 12, 1269, 10.1101/gad.12.9.1269

Forman, 1998, Androstane metabolites bind to and deactivate the nuclear receptor CAR-β, Nature, 395, 612, 10.1038/26996

Kozak, 1996, Genetic mapping of gene encoding the farnesoid receptor, Fxr, to mouse Chromosome 10, Mamm Genome, 7, 164, 10.1007/s003359900042

Blumberg, 1998, SXR, a novel steroid and xenobiotic sensing nuclear receptor, Genes Dev, 12, 3195, 10.1101/gad.12.20.3195

Willy, 1995, LXR, a nuclear receptor that defines a distinct retinoid response pathway, Genes Dev, 9, 1033, 10.1101/gad.9.9.1033

Bertilsson, 1998, Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction, Proc Natl Acad Sci U S A, 95, 12208, 10.1073/pnas.95.21.12208

Kliewer, 1998, An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway, Cell, 92, 73, 10.1016/S0092-8674(00)80900-9

Miyamoto, 1998, Promotion of agonist activity of antiandrogens by the androgen receptor co-activator, ARA70, in human prostate cancer DU145 cells, Proc Natl Acad Sci USA, 95, 7379, 10.1073/pnas.95.13.7379

Alen, 1999, Interaction of the putative androgen receptor-specific co-activator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform, Mol Endocrinol, 13, 117, 10.1210/me.13.1.117

Janknecht, 1996, Transcription, Nature, 383, 22, 10.1038/383022a0

Janknecht, 1996, Versatile molecular glue, Transcriptional control. Curr Biol, 6, 951, 10.1016/S0960-9822(02)00636-X

Kim, 1998, Efficient recruitment of TFIIB and CBP-RNA polymerase II holoenzyme by an interferon-β enhanceosome in vitro, Proc Natl Acad Sci USA, 95, 12191, 10.1073/pnas.95.21.12191

Nolte, 1998, Ligand binding and co-activator assembly of the peroxisome proliferator- activated receptor-γ, Nature, 395, 137, 10.1038/25931

Hanstein, 1996, P300 is a component of an estrogen receptor co-activator complex, Proc Natl Acad Sci USA, 93, 11540, 10.1073/pnas.93.21.11540

Chakravarti, 1996, Role of CBP/P300 in nuclear receptor signaling, Nature, 383, 99, 10.1038/383099a0

Ogryzko, 1996, The transcriptional co-activators p300 and CBP are histone acetyltransferases, Cell, 87, 953, 10.1016/S0092-8674(00)82001-2

Ogryzko, 1998, Histone-like TAFs within the PCAF histone acetylase complex [see comments], Cell, 94, 35, 10.1016/S0092-8674(00)81219-2

Fronsdal, 1998, CREB binding protein is a co-activator for the androgen receptor and mediates cross-talk with AP-1, J Biol Chem, 273, 31853, 10.1074/jbc.273.48.31853

Wang, 1998, SRC-1 and GRIP1 co-activate transcription with hepatocyte nuclear factor 4, J Biol Chem, 273, 30847, 10.1074/jbc.273.47.30847

Jain, 1998, Differential expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) and its co-activators steroid receptor co-activator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse, Am J Pathol, 153, 349, 10.1016/S0002-9440(10)65577-0

Subramaniam, 1999, Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids, J Biol Chem, 274, 18121, 10.1074/jbc.274.25.18121

Treuter, 1998, A regulatory role for RIP140 in nuclear receptor activation, Mol Endocrinol, 12, 864, 10.1210/me.12.6.864

Onate, 1998, The steroid receptor co-activator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors, J Biol Chem, 273, 12101, 10.1074/jbc.273.20.12101

Hanstein, 1999, Functional analysis of a novel estrogen receptor-b isoform, Mol Endocrinol, 13, 129, 10.1210/me.13.1.129

Norris, 1998, Enhancement of estrogen receptor transcriptional activity by the co-activator GRIP-1 highlights the role of activation function 2 in determining estrogen receptor pharmacology, J Biol Chem, 273, 6679, 10.1074/jbc.273.12.6679

Saatcioglu, 1997, Mutations in the conserved C terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity, Mol Cell Biol, 17, 4687, 10.1128/MCB.17.8.4687

Walfish, 1997, Yeast hormone response element assays detect and characterize GRIP1 co-activator-dependent activation of transcription by thyroid and retinoid nuclear receptors, Proc Natl Acad Sci USA, 94, 3697, 10.1073/pnas.94.8.3697

Kim, 1998, Molular cloning of xSRC-3, a novel transcription co-activator from Xenopus, that is related to AIB1, p/CIP, and TIF2, Mol Endocrinol, 12, 1038, 10.1210/mend.12.7.0139

Muchardt, 1993, A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor, EMBO J, 12, 4279, 10.1002/j.1460-2075.1993.tb06112.x

Le Douarin, 1996, Ligand-dependent interaction of nuclear receptors with potential transcriptional intermediary factors (mediators), Philos Trans R Soc Lond B Biol Sci, 351, 569, 10.1098/rstb.1996.0056

Owen-Hughes, 1996, Persistent site-specific remodeling of a nucleosome array by transient action of the SWI/SNF complex, Science, 273, 513, 10.1126/science.273.5274.513

Fondell, 1999, Thyroid hormone receptor-associated proteins and general positive cofactors mediate thyroid hormone receptor function in the absence of the TATA box-binding protein-associated factors of TFIID, Proc Natl Acad Sci USA, 96, 1959, 10.1073/pnas.96.5.1959

Ito, 1999, Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators, Mol Cell, 3, 361, 10.1016/S1097-2765(00)80463-3

Treuter, 1999, Competition between thyroid hormone receptor-associated protein (TRAP) 220 and transcriptional intermediary factor (TIF) 2 for binding to nuclear receptors, Implications for the recruitment of TRAP and p160 co-activator complexes. J Biol Chem, 274, 6667

Rubin, 1996, Identification of the gal4 suppressor Sug1 as a subunit of the yeast 26S proteasome, Nature, 379, 655, 10.1038/379655a0

Rubin, 1997, ATPase and ubiquitin-binding proteins of the yeast proteasome, Mol Biol Rep, 24, 17, 10.1023/A:1006844305067

Finley, 1998, Unified nomenclature for subunits of the Saccharomyces cerevisiae proteasome regulatory particle [letter], Trends Biochem Sci, 23, 244, 10.1016/S0968-0004(98)01222-5

Lee, 1995, Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor, Mol Endocrinol, 9, 243, 10.1210/me.9.2.243

Wagner, 1998, The nuclear co-repressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor, Mol Cell Biol, 18, 1369, 10.1128/MCB.18.3.1369

Wahli, 1991, Superfamily of steroid nuclear receptors, FASEB J, 5, 2243, 10.1096/fasebj.5.9.1860615

Pace, 1997, Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha, J Biol Chem, 272, 25832, 10.1074/jbc.272.41.25832

Bhat RA, Harnish DC, Stevis PE, Lyttle CR, Komm BS. A novel human estrogen receptor beta: identification and functional analysis of additional N terminal amino acids. J Steroid Biochem Mol Biol 1998:233–40.

Sande, 1996, Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors, Mol Endocrinol, 10, 813, 10.1210/me.10.7.813

Wong, 1998, Components of the SMRT co-repressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6, J Biol Chem, 273, 27695, 10.1074/jbc.273.42.27695

Guiochon–Mantel, 1996, Intracellular traffic of steroid hormone receptors, J Steroid Biochem Mol Biol, 56, 1, 10.1016/0960-0760(95)00268-5

Pratt, 1997, Steroid receptor interactions with heat shock protein and immunophilin chaperones, Endocr Rev, 18, 306, 10.1210/er.18.3.306

Naar, 1998, Chromatin, TAFs, and a novel multiprotein co-activator are required for synergistic activation by Sp1 and SREBP-1a in vitro, Genes Dev, 12, 3020, 10.1101/gad.12.19.3020